Evidence map›Paper›PMID 30286746›Full record

Trial reportBMC public health2018

"How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.

Sarah MacCarthy, Uzaib Saya, Clare Samba, Josephine Birungi, Stephen Okoboi, Sebastian Linnemayr

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02514356 (A Small Randomized Controlled Trial Providing Weekly Information by SMS About Own and Group-level ARV Adherence to Patients in Two Clinics in Uganda), which is not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02514356 nacompletednot on this map

A Small Randomized Controlled Trial Providing Weekly Information by SMS About Own and Group-level ARV Adherence to Patients in Two Clinics in Uganda

TypeinterventionalSponsorRANDRan2015 to 2017Enrolled147ConditionsHuman Immunodeficiency VirusArmsOwn adherence, Own and group level adherence
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah MacCarthyRAND Corporation, Behavioral and Policy Sciences, 1776 Main Street, Santa Monica, CA, USA. sarahm@rand.org.ORCID http://orcid.org/0000-0001-6468-8009
Uzaib SayaPardee RAND Graduate School, 1776 Main Street, Santa Monica, CA, USA.
Clare SambaTASO Uganda, Old Mulago Complex, Kampala, P.O.Box 10443, Kampala, Uganda.
Josephine BirungiTASO Uganda, Old Mulago Complex, Kampala, P.O.Box 10443, Kampala, Uganda.
Stephen OkoboiInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Sebastian LinnemayrRAND Corporation, Economics, Sociology, and Statistics, 1776 Main Street, Santa Monica, CA, USA.

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
SMS as an Incentive To Adhere (SITA)R21MH107218 · NIMH · RAND CORPORATION · PI LINNEMAYR, SEBASTIAN · 2015 to 2016
$386k
National Institute of Mental Health MH107218NIMH NIH HHS P30 MH058107NIMH NIH HHS R21 MH107218
6 · The paper itself

Abstract

backgroundStudies from sub-Saharan Africa (SSA) document how barriers to ART adherence present additional complications among adolescents and young adults living with HIV. We qualitatively explored barriers to ART adherence in Uganda among individuals age 14-24 to understand the unique challenges faced by this age group.

methodsWe conducted focus group (FG) discussions with Community Advisory Board members (n = 1), health care providers (n = 2), and male and female groups of adolescents age 14-17 (n = 2) and youth age 18-24 (n = 2) in Kampala, Uganda. FGs were transcribed verbatim and translated from Luganda into English. Two investigators independently reviewed all transcripts, developed a detailed codebook, achieved a pooled Cohen's Kappa of 0.79 and 0.80, and used a directed content analysis to identify key themes.

resultsFour barriers to ART adherence emerged: 1) poverty limited adolescents' ability to buy food and undercut efforts to become economically independent in their transition from adolescence to adulthood; 2) school attendance limited their privacy, further disrupting ART adherence; 3) family support was unreliable, and youth often struggled with a constant change in guardianship because they had lost their biological parents to HIV. In contrast peer influence, especially among HIV-positive youth, was strong and created an important network to support ART adherence; 4) the burden of taking multiple medications daily frustrated youth, often leading to so-called 'drug holidays.' Adolescent and youth-specific issues around disclosure emerged across three of the four barriers.

conclusionsTo be effective, programs and policies to improve ART adherence among youth in Uganda must address the special challenges that adolescents and young adults confront in achieving optimal adherence. For example, training on budgeting and savings practices could help promote their transition to financial independence. School staff could develop strategies to help students take their medications consistently and confidentially. While challenging to extend the range of services provided by HIV clinics, successful efforts will require engaging the family, peers, and larger community of health and educational providers to support adolescents and young adults living with HIV to live longer and healthier lives.

trial registrationClinicalTrials.gov Identifier: NCT02514356 . Registered August 3, 2015.

Indexed as

Health Services AccessibilityAdolescentAnti-Retroviral AgentsDisclosureFamilyFemaleFocus GroupsHIV InfectionsHumansMaleMedication AdherencePovertyPrivacyQualitative ResearchSocial SupportStudentsAnti-Retroviral AgentsAdolescents/youthART adherenceHIV/AIDSHIV infections/prevention & control/transmissionUgandaYoung adult

Identifiers

PMID30286746
PMCPMC6172755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.